The Discounted Cash Flow (DCF) valuation of Homology Medicines Inc (FIXX) is (2,178.26) USD. With the latest stock price at 24.55 USD, the upside of Homology Medicines Inc based on DCF is -8972.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
WACC / Discount Rate | 5.2% - 7.4% | 6.3% |
Long-term Growth Rate | 3.0% - 4.9% | 4.0% |
Fair Price | (19,657.22) - (1,188.56) | (2,178.26) |
Upside | -80170.2% - -4941.4% | -8972.7% |